Shekeab Jauhari
Medical Oncology · Lake Mary, FLNPI 1417394149
Payments from drug & device makers
Across 149 payments — averaging $10,862 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$1.1M
- Eli Lilly$418K
- Bristol Myers Squibb$34K
- Genentech, Inc.$12K
- Exelixis Inc.$8K
- AstraZeneca$305
- plus $2K from 25 others
Across 1 payment — averaging $34,556 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$35K
What the payments were for
- Speaking & faculty fees$93832%
- Food & beverage$1,98868%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 49 | $1,145,056 |
| Eli Lilly | 16 | $417,818 |
| Bristol Myers Squibb | 5 | $33,506 |
| Genentech, Inc. | 1 | $11,650 |
| Exelixis Inc. | 5 | $8,495 |
| AstraZeneca | 4 | $305 |
| Johnson & Johnson | 10 | $207 |
| Beone Medicines USA, Inc. | 1 | $143 |
| Novartis | 7 | $141 |
| Genentech USA, Inc. | 3 | $137 |
| Pharmacyclics LLC, An Abbvie Company | 6 | $120 |
| Astellas Pharma US Inc | 7 | $113 |
| AbbVie | 5 | $92 |
| Incyte Corporation | 4 | $87 |
| Eisai Inc. | 2 | $56 |
| Seagen Inc. | 3 | $51 |
| Amgen | 2 | $51 |
| Daiichi Sankyo Inc. | 2 | $39 |
| Gilead(2 entities) | 2 | $39 |
| Lilly USA, LLC | 3 | $39 |
| Tesaro, Inc. | 1 | $29 |
| Global Blood Therapeutics, Inc. | 2 | $29 |
| Advanced Accelerator Applications | 1 | $25 |
| E.r. Squibb & Sons, L.L.C. | 1 | $25 |
| Sanofi | 1 | $24 |
| Taiho Oncology, Inc. | 1 | $21 |
| GE HealthCare | 1 | $17 |
| Morphosys, US Inc. | 1 | $17 |
| GSK | 1 | $16 |
| G1 Therapeutics, Inc. | 1 | $14 |
| Array Biopharma Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,618,378 in reported general payments places this provider in the 85th percentile of 507 medical oncology providers in Florida.
Other medical oncology in Lake Mary
- Alexander PhilipovskiyLake Mary$1.9M
- Zeynep ErogluTampa$30.9M
- Manish PatelSarasota$29.7M
- Jad ChahoudTampa$21.8M
- Maen HusseinTavares$18.4M
- Patrick HwuTampa$18M
- Gail WrightHudson$13.8M
- Adil DaudTampa$13.3M
- Lowell HartFort Myers$10.1M
- Judy WangSarasota$9.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.